Brain-derived neurotrophic factor (BDNF) serum level in women with first-episode depression, correlation with clinical and metabolic parameters

References

• Whiteford HA, Degenhardt L, Rehm J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575–1586.
   PubMed Web of Science ®Google Scholar
• Ansorge MS, Hen R, Gingrich JA. Neurodevelopmental origins of depressive disorders. Curr Opin Pharmacol. 2007;7:8–17.
   PubMed Web of Science ®Google Scholar
• Lima-Ojeda JM, Rupprecht R, Baghai TC. Neurobiology of depression: a neurodevelopmental approach. World J Biol Psychiatry. 2017. DOI: 10.1080/15622975.2017.
   PubMedGoogle Scholar
• Shoval G, Weizman A. The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eur Neuropsychopharmacol. 2005;15:319–329.
   PubMed Web of Science ®Google Scholar
• Angelucci F, Brene S, Mathe AA. BDNF in schizophrenia, depression and corresponding animal models. Mol Psychiatry. 2005;10:345–352.
   PubMed Web of Science ®Google Scholar
• Mattson MP. Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann N Y Acad Sci. 2008;1144:97–112.
   PubMed Web of Science ®Google Scholar
• Numakawa T, Suzuki S, Kumamaru E, et al. BDNF function and intracellular signaling in neurons. Histol Histopathol. 2010;25:237–258.
   PubMed Web of Science ®Google Scholar
• Wetmore C, Ernfors P, Persson H, et al. Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridization. Exp Neurol. 1990;109:141–152.
   PubMed Web of Science ®Google Scholar
• Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006;59:1116–1127.
   PubMed Web of Science ®Google Scholar
• Lang UE, Hellweg R, Gallinat J. BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology. 2004;29:795–798.
   PubMed Web of Science ®Google Scholar
• Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008;64:527–532.
   PubMed Web of Science ®Google Scholar
• Maisonpierre PC, Le Beau MM, Espinosa R, et al. Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations. Genomics. 1991;10:558–568.
   PubMed Web of Science ®Google Scholar
• Aid T, Kazantseva A, Piirsoo M, et al. Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res. 2007;85:525–535.
   PubMed Web of Science ®Google Scholar
• Motamedi S, Karimi I, Jafari F. The interrelationship of metabolic syndrome and neurodegenerative diseases with focus on brain-derived neurotrophic factor (BDNF): kill two birds with one stone. Metab Brain Dis. 2017;32:651–665.
   PubMed Web of Science ®Google Scholar
• Pan W, Banks WA, Fasold MB, et al. Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology. 1998;37:1553–1561.
   PubMed Web of Science ®Google Scholar
• Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett. 2002;328:261–264.
   PubMed Web of Science ®Google Scholar
• Cattaneo A, Cattane N, Begni V, et al. The human BDNF gene: peripheral gene expression and protein levels as biomarkers for psychiatric disorders. Transl Psychiatry. 2016;6:e958.
   PubMed Web of Science ®Google Scholar
• Li M, Chang H, Xiao X. BDNF Val66Met polymorphism and bipolar disorder in European populations: A risk association in case-control, family-based and GWAS studies. Neurosci Biobehav Rev. 2016;68:218–233.
   PubMed Web of Science ®Google Scholar
• Fernandes BS, Molendijk ML, Kohler CA, et al. Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies. BMC Med. 2015;13:289.
   PubMed Web of Science ®Google Scholar
• Rzewuska M. [Metabolic risk during antipsychotic treatment in patients with schizophrenia]. Psychiatr Pol. 2007;41:457–472.
   PubMedGoogle Scholar
• Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem. 2013;31:761–777.
   PubMed Web of Science ®Google Scholar
• Malhotra N, Grover S, Chakrabarti S, et al. Metabolic syndrome in schizophrenia. Indian J Psychol Med. 2013;35:227–240.
   PubMedGoogle Scholar
• Ohmori Y, Ito H, Morita A, et al. Associations between depression and unhealthy behaviours related to metabolic syndrome: a cross sectional study. Asia Pac J Clin Nutr. 2017;26:130–140.
   PubMed Web of Science ®Google Scholar
• Duan W, Guo Z, Jiang H, et al. Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology. 2003;144:2446–2453.
   PubMed Web of Science ®Google Scholar
• Rothman SM, Griffioen KJ, Wan R, et al. Brain-derived neurotrophic factor as a regulator of systemic and brain energy metabolism and cardiovascular health. Ann N Y Acad Sci. 2012;1264:49–63.
   PubMed Web of Science ®Google Scholar
• Golden E, Emiliano A, Maudsley S, et al. Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging. PLoS One. 2010;5:e10099.
   PubMed Web of Science ®Google Scholar
• Kaess BM, Preis SR, Lieb W, et al. Circulating brain-derived neurotrophic factor concentrations and the risk of cardiovascular disease in the community. J Am Heart Assoc. 2015;4:e001544.
   PubMed Web of Science ®Google Scholar
• Amare AT, Schubert KO, Klingler-Hoffmann M, et al. The genetic overlap between mood disorders and cardiometabolic diseases: a systematic review of genome wide and candidate gene studies. Transl Psychiatry. 2017;7:e1007.
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington (DC) American Psychiatric Press, Inc. 1996.
   Google Scholar
• McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system [News]. Arch Gen Psychiatry. 1991;48:764–770.
   PubMed Web of Science ®Google Scholar
• Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62.
   PubMed Web of Science ®Google Scholar
• Schmitt AB, Bauer M, Volz HP, et al. Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity. Eur Arch Psychiatry Clin Neurosci. 2009;259:329–339.
   PubMed Web of Science ®Google Scholar
• Faul F, Erdfelder E, Lang AG, et al. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–191.
   PubMed Web of Science ®Google Scholar
• Wysokinski A. Serum levels of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) in depressed patients with schizophrenia. Nord J Psychiatry. 2016;70:267–271.
   PubMed Web of Science ®Google Scholar
• Polyakova M, Schroeter ML, Elzinga BM, et al. Brain-derived neurotrophic factor and antidepressive effect of electroconvulsive therapy: systematic review and meta-analyses of the preclinical and clinical literature. PLoS One. 2015;10:e0141564.
   PubMed Web of Science ®Google Scholar
• Munkholm K, Vinberg M, Kessing LV. Peripheral blood brain-derived neurotrophic factor in bipolar disorder: a comprehensive systematic review and meta-analysis. Mol Psychiatry. 2016;21:216–228.
   PubMed Web of Science ®Google Scholar
• Chiou YJ, Huang TL. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naive first-episode major depressive disorder: effects of antidepressants. Int J Neuropsychopharmacol. 2017;20:213–218.
   PubMed Web of Science ®Google Scholar
• Yoshimura R, Kishi T, Hori H, et al. Serum proBDNF/BDNF and response to fluvoxamine in drug-naive first-episode major depressive disorder patients. Ann Gen Psychiatry. 2014;13:19.
   PubMed Web of Science ®Google Scholar
• Aydemir O, Deveci A, Taneli F. The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:261–265.
   PubMed Web of Science ®Google Scholar
• Lee BH, Kim H, Park SH, et al. Decreased plasma BDNF level in depressive patients. J Affect Disord. 2007;101:239–244.
   PubMed Web of Science ®Google Scholar
• Chen DC, Wang J, Wang B, et al. Decreased levels of serum brain-derived neurotrophic factor in drug-naive first-episode schizophrenia: relationship to clinical phenotypes. Psychopharmacology. 2009;207:375–380.
   PubMed Web of Science ®Google Scholar
• Karlovic D, Serretti A, Jevtovic S, et al. Diagnostic accuracy of serum brain derived neurotrophic factor concentration in antidepressant naïve patients with first major depression episode. J Psychiatr Res. 2013;47:162–167.
   PubMed Web of Science ®Google Scholar
• Vinberg M, Bukh JD, Bennike B, et al. Are variations in whole blood BDNF level associated with the BDNF Val66Met polymorphism in patients with first episode depression? Psychiatry Res. 2013;210:102–108.
   PubMed Web of Science ®Google Scholar
• Kheirouri S, Noorazar SG, Alizadeh M, et al. Elevated brain-derived neurotrophic factor correlates negatively with severity and duration of major depressive episodes. Cogn Behav Neurol. 2016;29:24–31.
   PubMed Web of Science ®Google Scholar
• Elfving B, Buttenschon HN, Foldager L, et al. Depression, the Val66Met polymorphism, age, and gender influence the serum BDNF level. J Psychiatr Res. 2012;46:1118–1125.
   PubMed Web of Science ®Google Scholar
• Tsuchimine S, Saito M, Kaneko S, et al. Decreased serum levels of polyunsaturated fatty acids and folate, but not brain-derived neurotrophic factor, in childhood and adolescent females with depression. Psychiatry Res. 2015;225:187–190.
   PubMed Web of Science ®Google Scholar
• Panizzutti B, Gubert C, Schuh AL, et al. Increased serum levels of eotaxin/CCL11 in late-stage patients with bipolar disorder: an accelerated aging biomarker? J Affect Disord. 2015;182:64–69.
   PubMed Web of Science ®Google Scholar
• Grande I, Magalhaes PV, Chendo I, et al. Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial. Acta Psychiatr Scand. 2014;129:393–400.
   PubMed Web of Science ®Google Scholar
• Jacoby AS, Munkholm K, Vinberg M, et al. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder – results from a prospective study. J Affect Disord. 2016;197:167–174.
   PubMed Web of Science ®Google Scholar
• da Graca Cantarelli M, Nardin P, Buffon A, et al. Serum triglycerides, but not cholesterol or leptin, are decreased in suicide attempters with mood disorders. J Affect Disord. 2015;172:403–409.
   PubMed Web of Science ®Google Scholar
• Lee SY, Chen SL, Chang YH, et al. Correlation of plasma brain-derived neurotrophic factor and metabolic profiles in drug-naïve patients with bipolar II disorder after a twelve-week pharmacological intervention. Acta Psychiatr Scand. 2015;131:120–128.
   PubMed Web of Science ®Google Scholar
• von Bibra H, Saha S, Hapfelmeier A, et al. Impact of the triglyceride/high-density lipoprotein cholesterol ratio and the hypertriglyceremic-waist phenotype to predict the metabolic syndrome and insulin resistance. Horm Metab Res. 2017;49:542–549.
   PubMed Web of Science ®Google Scholar
• Mansur RB, Santos CM, Rizzo LB, et al. Brain-derived neurotrophic factor, impaired glucose metabolism, and bipolar disorder course. Bipolar Disord. 2016;18:373–378.
   PubMed Web of Science ®Google Scholar
• Lin CC, Hung YY, Tsai MC, et al. Increased serum brain-derived neurotrophic factor in male schizophrenic patients with metabolic syndrome. Medicine. 2017;96:e7089.
   PubMed Web of Science ®Google Scholar
• Nurjono M, Tay YH, Lee J. The relationship between serum brain-derived neurotrophic factor (BDNF) and cardiometabolic indices in schizophrenia. Schizophr Res. 2014;157:244–248.
   PubMed Web of Science ®Google Scholar
• Zhou C, Zhong J, Zou B, et al. Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression. PLoS One. 2017;12:e0172270.
   PubMed Web of Science ®Google Scholar
• Chan MK, Cooper JD, Bot M, et al. Blood-based immune-endocrine biomarkers of treatment response in depression. J Psychiatr Res. 2016;83:249–259.
   PubMed Web of Science ®Google Scholar
• Sigitova E, Fisar Z, Hroudova J, et al. Biological hypotheses and biomarkers of bipolar disorder. Psychiatry Clin Neurosci. 2017;71:77–103.
   PubMed Web of Science ®Google Scholar